- Home
- ITRG vs TIL Comparison
ITRG vs TIL Comparison
Compare ITRG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- TIL
- Stock Information
- Founded
- ITRG 1997
- TIL 2018
- Country
- ITRG Canada
- TIL United States
- Employees
- ITRG N/A
- TIL N/A
- Industry
- ITRG Precious Metals
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- TIL Health Care
- Exchange
- ITRG Nasdaq
- TIL Nasdaq
- Market Cap
- ITRG 452.9M
- TIL 177.1M
- IPO Year
- ITRG N/A
- TIL 2021
- Fundamental
- Price
- ITRG $2.72
- TIL $21.03
- Analyst Decision
- ITRG Strong Buy
- TIL Buy
- Analyst Count
- ITRG 2
- TIL 6
- Target Price
- ITRG $3.25
- TIL $120.50
- AVG Volume (30 Days)
- ITRG 2.2M
- TIL 150.1K
- Earning Date
- ITRG 11-12-2025
- TIL 11-12-2025
- Dividend Yield
- ITRG N/A
- TIL N/A
- EPS Growth
- ITRG N/A
- TIL N/A
- EPS
- ITRG 0.09
- TIL N/A
- Revenue
- ITRG $148,447,000.00
- TIL N/A
- Revenue This Year
- ITRG $871.24
- TIL N/A
- Revenue Next Year
- ITRG N/A
- TIL N/A
- P/E Ratio
- ITRG $29.26
- TIL N/A
- Revenue Growth
- ITRG N/A
- TIL N/A
- 52 Week Low
- ITRG $0.79
- TIL $10.80
- 52 Week High
- ITRG $2.86
- TIL $73.69
- Technical
- Relative Strength Index (RSI)
- ITRG 70.83
- TIL 37.54
- Support Level
- ITRG $2.52
- TIL $20.11
- Resistance Level
- ITRG $2.86
- TIL $25.89
- Average True Range (ATR)
- ITRG 0.14
- TIL 2.57
- MACD
- ITRG -0.00
- TIL -0.69
- Stochastic Oscillator
- ITRG 79.58
- TIL 6.70
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.